Genpharmasec Ltd Confirms No Deviation in Use of Rights Issue Proceeds as of December 31, 2025

Genpharmasec Ltd has released a statement confirming no deviation or variation in the use of proceeds from their Rights Issue. The company has utilized the funds as per the objects stated in the Letter of Offer. The Audit Committee has reviewed the statement, and there is no deviation or variation in the utilization of these proceeds. The funds were used for various purposes including acquiring equity shares, repaying or prepaying borrowings, part financing the working capital, meeting general corporate purposes, and meeting the expenses of the issue.